Epigallocatechin-3-gallate alleviates type 2 diabetes mellitus via β-cell function improvement and insulin resistance reduction

OBJECTIVE(S): Epigallocatechin-3-gallate (EGCG) has a good therapeutic effect on type 2 diabetes mellitus (T2DM). This work was designed to explore EGCG’s effectiveness in insulin resistance (IR) and pancreas islet β-cell function in a rat model of T2DM. MATERIALS AND METHODS: Eight-week-old male Sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Tiantian, Li, Minghui, Zhu, Moli, Liu, Xu, Huang, Keke, Li, Wenru, Wang, Shuang-Xi, Yin, Yaling, Li, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mashhad University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150804/
https://www.ncbi.nlm.nih.gov/pubmed/35656076
http://dx.doi.org/10.22038/IJBMS.2022.58591.13016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150804/
https://www.ncbi.nlm.nih.gov/pubmed/35656076
http://dx.doi.org/10.22038/IJBMS.2022.58591.13016

Ejemplares similares